Cargando…

Accelerating the elimination of hepatitis C in Kuwait: An expert opinion

The hepatitis C virus (HCV) is estimated to affect 71 million people worldwide. In 2016, the World Health Organization adopted the first global health sector strategy to eliminate viral hepatitis as a public health threat by 2030. In December 2018, the European Association for the Study of the Liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasan, Fuad, Alfadhli, Ahmad, Al-Gharabally, Abeer, Alkhaldi, Mahmoud, Colombo, Massimo, Lazarus, Jeffrey V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438195/ https://www.ncbi.nlm.nih.gov/pubmed/32874054 http://dx.doi.org/10.3748/wjg.v26.i30.4415

Ejemplares similares

Expert opinion on the management of hepatitis C infection in Kuwait
por: Saad, Motaz Fathy, et al.
Publicado: (2018)

Elimination of Hepatitis B: Is It a Mission Possible?
por: Tseng, Tai-Chung, et al.
Publicado: (2017)

Impact of coronavirus disease 2019 on prevention and elimination strategies for hepatitis B and hepatitis C
por: Rehman, Syed Tabish, et al.
Publicado: (2021)

Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
por: Lazarus, Jeffrey V., et al.
Publicado: (2023)

Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
por: Omran, Dalia, et al.
Publicado: (2018)

Hepatitis C virus micro-elimination: Where do we stand?
por: Mangia, Alessandra, et al.
Publicado: (2021)

Radiofrequency ablation for hepatic hemangiomas: A consensus from a Chinese panel of experts
por: Gao, Jun, et al.
Publicado: (2017)

Metabolic aspects of hepatitis C virus
por: El-Kassas, Mohamed, et al.
Publicado: (2022)

Current opinion on the regulation of small intestinal magnesium absorption
por: Chamniansawat, Siriporn, et al.
Publicado: (2023)

The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination
por: Geric, C., et al.
Publicado: (2023)

Using Wolbachia to Eliminate Dengue: Will the Virus Fight Back?
por: Edenborough, Kathryn M., et al.
Publicado: (2021)

Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
por: Crismale, James F, et al.
Publicado: (2019)

Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Experts Opinion
por: Goldberg, Ivan, et al.
Publicado: (2012)

Expert Opinion
Publicado: (1920)

Hepatitis B in patients with hematological diseases: An update
por: Coluccio, Chiara, et al.
Publicado: (2017)

Hydrocodone, Oxycodone, and Morphine Metabolism and Drug–Drug Interactions
por: Coates, Shelby, et al.
Publicado: (2023)

Expert opinion on the treatment of patients with chronic hepatitis C
por: Zeuzem, S, et al.
Publicado: (2009)

Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic Diseases
por: AlEnizi, Ahmad, et al.
Publicado: (2018)

Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
por: Kamal, Ahmed, et al.
Publicado: (2022)

Epidemiological and clinical aspects of hepatitis B virus infection in Italy over the last 50 years
por: Sagnelli, Caterina, et al.
Publicado: (2022)

Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System
por: Tanios, Bassem Y., et al.
Publicado: (2012)

COVID-19 and comorbidities of hepatic diseases in a global perspective
por: Ahmad, Aqsa, et al.
Publicado: (2021)

Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients
por: Ahsan, Khansa, et al.
Publicado: (2023)

A Randomized Clinical Trial Comparing Triple Therapy versus Non-bismuth based Quadruple Therapy for the Eradication of Helicobacter Pylori in Kuwait
por: Alfadhli, Ahmad, et al.
Publicado: (2022)

Accelerated partial breast irradiation: Past, present, and future
por: Tann, Anne W, et al.
Publicado: (2016)

More Expert Opinion
Publicado: (1920)

Impact of hepatitis B virus infection on hepatic metabolic signaling pathway
por: Shi, Yi-Xian, et al.
Publicado: (2016)

Pathogenesis of autoimmune hepatitis
por: Fan, Jun-Hua, et al.
Publicado: (2021)

Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA
por: Sekiba, Kazuma, et al.
Publicado: (2018)

Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis
por: Harputluoglu, Murat, et al.
Publicado: (2022)

Linking biosynthetic and chemical space to accelerate microbial secondary metabolite discovery
por: Soldatou, Sylvia, et al.
Publicado: (2019)

Hepatic senescence, the good and the bad
por: Huda, Nazmul, et al.
Publicado: (2019)

Artificial intelligence for hepatitis evaluation
por: Liu, Wei, et al.
Publicado: (2021)

Viral hepatitis: Innovations and expectations
por: Leoni, Simona, et al.
Publicado: (2022)

Seronegative autoimmune hepatitis in childhood
por: Islek, Ali, et al.
Publicado: (2023)

Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings
por: Said, Zeinab Nabil Ahmed, et al.
Publicado: (2022)

Molecular orchestration of the hepatic circadian symphony
por: Albrecht, Urs
Publicado: (2006)

Hepatic hydrothorax: An update and review of the literature
por: Garbuzenko, Dmitry Victorovich, et al.
Publicado: (2017)

Hepatitis B in renal transplant patients
por: Marinaki, Smaragdi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jb2dbfk1k6nksri5ehhfdskksc